Desensitization of G protein-coupled receptors and neuronal functions

Annual Review of Neuroscience

Volumn 27, Issue , 2004, Pages 107-144

  Gainetdinov, Raul R ^a   Premont, Richard T ^a   Bohn, Laura M ^a,b   Lefkowitz, Robert J ^a   Caron, Marc G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Antinociception; Opiates; Psychostimulants; Sensitization; Tolerance

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; AMPHETAMINE; APOMORPHINE; BETA ARRESTIN; BETA ARRESTIN 1; BETA ARRESTIN 2; COCAINE; CONE ARRESTIN; DEXAMPHETAMINE; DOPAMINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; G PROTEIN COUPLED RECEPTOR KINASE 1; G PROTEIN COUPLED RECEPTOR KINASE 2; G PROTEIN COUPLED RECEPTOR KINASE 3; G PROTEIN COUPLED RECEPTOR KINASE 4; G PROTEIN COUPLED RECEPTOR KINASE 5; G PROTEIN COUPLED RECEPTOR KINASE 6; G PROTEIN COUPLED RECEPTOR KINASE 7; MU OPIATE RECEPTOR; QUINPIROLE; UNCLASSIFIED DRUG;

ANALGESIA; BEHAVIOR; BRAIN FUNCTION; DOSE RESPONSE; HUMAN; KNOCKOUT MOUSE; LOCOMOTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; RECEPTOR SENSITIVITY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ARRESTINS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; HUMANS; NEURONS; PHOSPHORYLATION; PROTEIN KINASES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, OPIOID, MU;

EID: 1642292051     PISSN: 0147006X     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.neuro.27.070203.144206     Document Type: Review

References (164)

1. Angers S, Salahpour A, Bouvier M. 2002. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42:409-35
2. Arriza JL, Dawson TM, Simerly RB, Martin LJ, Caron MG, et al. 1992. The G protein-coupled receptor kinases βARK1 and βARK2 are widely distributed at synapses in rat brain. J. Neurosci. 12:4045-55
3. Attramadal H, Arriza JL, Aoki C, Dawson TM, Codina J, et al. 1992. Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J. Biol. Chem. 267:17882-90
4. Barren TB, Hauger RL, Kennedy JL, Sadovnick AD, Remick RA, et al. 2003. Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder. Mol. Psychiatry 8:546-57
5. Benovic JL, Mayor F Jr, Staniszewski C, Lefkowitz RJ, Caron MG. 1987. Purification and characterization of the beta-adrenergic receptor kinase. J. Biol. Chem. 262:9026-32
6. Benovic JL, Gomez J. 1993. Molecular cloning and expression of GRK6. A new member of the G protein-coupled receptor kinase family. J. Biol. Chem. 268:19521-27
7. Berman DM, Gilman AG. 1998. Mammalian RGS proteins: barbarians at the gate. J. Biol. Chem. 273:1269-72
8. Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, et al. 2001. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410:376-80
9. Boekhoff I, Inglese J, Schleicher S, Koch WJ, Lefkowitz RJ, Breer H. 1994. Olfactory desensitization requires membrane targeting of receptor kinase mediated by beta gamma-subunits of heterotrimeric G proteins. J Biol. Chem. 269:37-40
10. Bohm SK, Grady EF, Bunnett NW. 1997. Regulatory mechanisms that modulate signaling by G-protein-coupled receptors. Biochem. J. 322:1-18
11. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT. 1999. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286:2495-98
12. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG. 2000. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408:720-23
13. Bohn LM, Lefkowitz RJ, Caron MG. 2002. Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J. Neurosci. 22: 10494-500
14. Bohn LM, Gainetdinov RR, Sotnikova TD, Lefkowitz RJ, Dykstra LA, Caron MG. 2003. Enhanced rewarding properties of morphine, but not cocaine, in βarrestin-2 knockout mice. J. Neurosci. 23:10265-73
15. Bushell T, Endoh T, Simen AA, Ren D, Bindokas VP, Miller RJ. 2002. Molecular components of tolerance to opiates in single hippocampal neurons. Mol. Pharmacol. 61: 55-64
16. Carlsson A. 2001. A paradigm shift in brain research. Science 294:1021-24
17. Celver JP, Lowe J, Kovoor A, Gurevich W, Chavkin C. 2001. Threonine 180 is required for G-protein-coupled receptor kinase 3- and beta-arrestin 2-mediated desensitization of the mu-opioid receptor in Xenopus oocytes. J. Biol. Chem. 276:4894-900
18. Chen CK, Bums ME, Spencer M, Niemi GA, Chen J, et al. 1999a. Abnormal photoresponses and light-induced apoptosis in rods lacking rhodopsin kinase. Proc. Natl. Acad. Sci. USA 96:3718-22
19. Chen J, Simon MI, Matthes MT, Yasumura D, LaVail MM. 1999b. Increased susceptibility to light damage in an arrestin knockout mouse model of Oguchi disease (stationary night blindness). Invest. Ophthalmol. Vis. Sci. 40:2978-82
20. Chen W, ten Berge D, Brown J, Ahn S, Hu LA, et al. 2003. Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. Science 301:1391-94
21. Cheng ZJ, Yu QM, Wu YL, Ma L, Pei G. 1998. Selective interference of beta-arrestin 1 with kappa and delta but not mu opioid receptor/G protein coupling. J. Biol. Chem. 273:24328-33
22. Claing A, Laporte SA, Caron MG, Lefkowitz RJ. 2002. Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins. Prog. Neurobiol. 66:61-79
23. Conner DA, Mathier MA, Mortensen RM, Christe M, Vatner SF, et al. 1997. beta-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation. Circ. Res. 81:1021-26
24. Diaz A, Pazos A, Florez J, Ayesta FJ, Santana V, Hurle MA. 2002. Regulation of muopioid receptors, G-protein-coupled receptor kinases and beta-arrestin 2 in the rat brain after chronic opioid receptor antagonism. Neuroscience 112:345-53
25. Di Chiara G, North RA. 1992. Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13:185-93
26. Dickey BF, Birnbaumer L, ed. 1993. GT-Pases in Biology (Handbook of Experimental Pharmacology). Berlin: Springer-Verlag. Vol. 108
27. 2+ channel inhibition. Neuron 16:579-85
28. Dohlman HG, Thorner J. 1997. RGS proteins and signaling by heterotrimeric G proteins. J. Biol. Chem. 272:3871-74
29. Eisinger DA, Ammer H, Schulz R. 2002. Chronic morphine treatment inhibits opioid receptor desensitization and internalization. J. Neurosci. 22:10192-200
30. Elmer GI, Pieper JO, Rubinstein M, Low MJ, Grandy DK, Wise RA. 2002. Failure of intravenous morphine to serve as an effective instrumental reinforcer in dopamine D2 receptor knock-out mice. J. Neurosci. 22:RC224
31. Erdtmann-Vourliotis M, Mayer P, Ammon S, Reichert U, Hollt V. 2001. Distribution of G protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain. Brain Res. Mol. Brain. Res. 95:129-37
32. Fan X, Zhang J, Zhang X, Yue W, Ma L. 2002. Acute and chronic morphine treatments and morphine withdrawal differentially regulate GRK2 and GRK5 gene expression in rat brain. Neuropharmacology 43:809-16
33. Fan XL, Zhang JS, Zhang XQ, Yue W, Ma L. 2003. Differential regulation of beta-arrestin 1 and beta-arrestin 2 gene expression in rat brain by morphine. Neuroscience 117:383-89
34. Fehr C, Fickova M, Hiemke C, Reuss S, Dahmen N. 1997. Molecular cloning of rat G-protein-coupled receptor kinase 6 (GRK6) from brain tissue, and its mRNA expression in different brain regions and peripheral tissues. Brain Res. Mol. Brain Res. 49:278-82
35. Ferguson SS, Downey WE 3rd, Colapietro AM, Barak LS, Menard L, Caron MG. 1996. Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 271:363-66
36. Ferguson SS, Zhang J, Barak LS, Caron MG. 1998. Molecular mechanisms of G protein-coupled receptor desensitization and resensitization. Life Sci. 62:1561-65
37. Fong AM, Premont RT, Richardson RM, Yu YR, Lefkowitz RJ, Patel DD. 2002. A positive regulatory role for the GRK-βarrestin system in lymphocyte chemotaxis. Proc. Natl. Acad. Sci. USA 99:7478-83
38. Gainetdinov RR, Bohn LM, Walker JKL, Laporte SA, Macrae AD, et al. 1999a. Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient mice. Neuron 24:1029-36
39. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG. 1999b. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397-401
40. Gainetdinov RR, Premont RT, Caron MG, Lefkowitz RJ. 2000. Reply: receptor specificity of G protein-coupled receptor kinases. Trends Pharmacol. Sci 21:366-67
41. Gainetdinov RR, Bohn LM, Sotnikova TD, Cyr M, Laakso A, et al. 2003a. Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron 38:291-303
42. Gainetdinov RR, Caron MG. 2003b. Mono-amine transporters: from genes to behavior. Annu. Rev. Pharmacol. Toxicol. 43:261-84
43. Gardner B, Liu ZF, Jiang D, Sibley DR. 2001. The role of phosphorylation/dephosphorylation in agonist-induced desensitization of D1 dopamine receptor function. Mol. Pharmacol. 59:310-21
44. Gomeza J, Shannon H, Kostenis E, Felder C, Zhang L, et al. 1999. Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc. Natl. Acad. Sci. USA 96:1692-97
45. Goodman OB Jr, Krupnick JG, Santini F, Gurevich W, Penn RB, et al. 1996. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 383:447-50
46. Grandy DK, Civelli O. 1992. G-protein-coupled receptors: the new dopamine receptor subtypes. Curr. Opin. Neurobiol. 2:275-81
47. Grange-Midroit M, Garcia-Sevilla JA, Ferrer-Alcon M, La Harpe R, Huguelet P, Guimon J. 2003. Regulation of GRK 2 and 6, beta-arrestin-2 and associated proteins in the prefrontal cortex of drug-free and antidepressant drug-treated subjects with major depression. Brain Res. Mol. Brain Res. 111:31-41
48. Gurevich EV, Benovic JL, Gurevich W. 2002. Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development. Neuroscience 109:421-36
49. Gurevich W, Gurevich EV. 2003. The new face of active receptor bound arrestin attracts new partners. Structure 11:1037-42
50. Haberstock H, Wein M, Barrot M, Colago EE, Rahman Z, et al. 2003. Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons. J. Neurosci. 23:4324-32
51. Hall RA, Premont RT, Lefkowitz RJ. 1999. Heptahelical receptor signaling: beyond the G protein paradigm. J. Cell Biol. 145:927-32
52. Hamm HE, Gilchrist A. 1996. Heterotrimeric G proteins. Curr. Opin. Cell Biol. 8:189-96
53. Hanks SK, Quinn AM, Hunter T. 1988. The proteinkinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241:42-52
54. Hausdorff WP, Caron MG, Lefkowitz RJ. 1990. Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J. 4:2881-89
55. Hornykiewicz O. 1966. Dopamine (3-hydroxytyramine) and brain function. Pharmacol. Rev. 18:925-64
56. Hurle MA. 2001. Changes in the expression of G protein-coupled receptor kinases and β-arrestin 2 in rat brain during opioid tolerance and supersensitivity. J. Neurochem. 77:486-92
57. Hyman SE, Malenka RC. 2001. Addiction and the brain: the neurobiology of compulsion and its persistence. Nature Rev. Neurosci. 2:695-703
58. Iacovelli L, Sallese M, Mariggio S, de Blasi A. 1999. Regulation of G-protein-coupled receptor kinase subtypes by calcium sensor proteins. FASEB J. 13:1-8
59. Iacovelli L, Salvatore L, Capobianco L, Picascia A, Barletta E, et al. 2003. Role of G protein-coupled receptor kinase 4 and beta-arrestin 1 in agonist-stimulated metabotropic glutamate receptor 1 internalization and activation of mitogen-activated protein kinases. J. Biol. Chem. 278:12433-42
60. Ito K, Haga T, Lameh J, Sadee W. 1999. Sequestration of dopamine D2 receptors depends on coexpression of G protein-coupled receptor kinases 2 or 5. Eur. J. Biochem. 260:112-19
61. Iwata K, Ito K, Fukuzaki A, Inaki K, Haga T. 1999. Dynamin and rab5 regulate GRK2-dependent internalization of dopamine D2 receptors. Eur. J. Biochem. 263:596-602
62. Jaber M, Koch WJ, Rockman H, Smith B, Bond RA, et al. 1996. Essential role of β-adrenergic receptor kinase 1 in cardiac development and function. Proc. Natl. Acad. Sci. USA 93:12974-79
63. Janowsky DS, Overstreet DH, Nurnberger JI Jr. 1994. Is cholinergic sensitivity a genetic marker for the affective disorders? Am. J. Med. Genet. 54:335-44
64. Janssen PA, Leysen JE, Megens AA, Awouters FH. 1999. Does phenylethylamine act as an endogenous amphetamine in some patients? Int. J. Neuropsychopharmacol. 2:229-40
65. Jenner P, Marsden CD. 1987. Chronic pharmacological manipulation of dopamine receptors in brain. Neuropharmacology 26:931-40
66. Jones SR, Gainetdinov RR, Wightman RM, Caron MG. 1998. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18:1979-86
67. Kabbani N, Negyessy L, Lin R, Goldman-Rakic P, Levenson R. 2002. Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. J. Neurosci. 22:8476-86
68. Kavelaars A, Vroon A, Raatgever R, Fong AM, Premont RT, et al. 2003. Increased acute inflammation, leukotriene B4-induced chemotaxis and signaling in mice deficient for GRK6. J. Immunol. 171:6128-34
69. Kieffer BL. 1999. Opioids: first lessons from knockout mice. Trends Pharmacol. Sci. 20: 19-26
70. Kim KM, Valenzano KJ, Robinson SR, Yao WD, Barak LS, Caron MG. 2001. Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and β-arrestins. J. Biol. Chem. 276:37409-14
71. Kittel A, Komori N. 1999. Ultrastructural localization of beta-arrestin-1 and -2 in rat lumbar spinal cord. J. Comp. Neurol. 412:649-55
72. Koh PO, Undie AS, Kabbani N, Levenson R, Goldman-Rakic PS, Lidow MS. 2003. Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proc. Natl. Acad. Sci. USA 100:313-17
73. Kohout TA, Lin FS, Perry SJ, Conner DA, Lefkowitz RJ. 2001. beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc. Natl. Acad. Sci. USA 98:1601-6
74. Koob GF. 1992. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:177-84
75. Kovoor A, Celver JP, Wu A, Chavkin C. 1998. Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy. Mol. Pharmacol. 54:704-11
76. Kunapuli P, Onorato JJ, Hosey MM, Benovic JL. 1994. Expression, purification, and characterization of the G protein-coupled receptor kinase GRK5. J. Biol. Chem. 269:1099-105
77. Laakso A, Mohn AR, Gainetdinov RR, Caron MG. 2002. Experimental genetic approaches to addiction. Neuron 36:213-28
78. Lamey M, Thompson M, Varghese G, Chi H, Sawzdargo M, et al. 2002. Distinct residues in the carboxyl tail mediate agonist-induced desensitization and internalization of the human dopamine D1 receptor. J. Biol. Chem. 277:9415-21
79. Laporte SA, Oakley RH, Zhang J, Holt JA, Ferguson SS, et al. 1999. The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc. Natl. Acad. Sci. USA 96:3712-17
80. Lefkowitz RJ. 1998. G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J. Biol. Chem. 273:18677-80
81. Li AH, Wang HL. 2001. G protein-coupled receptor kinase 2 mediates mu-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus. J. Neurochem. 77:435-44
82. Loh HH, Liu HC, Cavalli A, Yang W, Chen YF, Wei LN. 1998. mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Brain Res. Mol. Brain Res. 54:321-26
83. Lodowski DT, Pitcher JA, Capel WD, Lefkowitz RJ, Tesmer JJ. 2003. Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gbe-tagamma. Science 300:1256-62
84. Lowe JD, Celver JP, Gurevich W, Chavkin C. 2002. mu-Opioid receptors desensitize less rapidly than delta-opioid receptors due to less efficient activation of arrestin. J. Biol. Chem. 277:15729-35
85. Luttrell LM, Lefkowitz RJ. 2002. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell. Sci. 115:455-65
86. Maldonado R, Saiardi A, Valverde O, Samad TA, Roques BP, Borrelli E. 1997. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388:586-89
87. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, et al. 1996. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383:819-23
88. Menard L, Ferguson SS, Barak LS, Bertrand L, Premont RT, et al. 1996. Members of the G protein-coupled receptor kinase family that phosphorylate the beta2-adrenergic receptor facilitate sequestration. Biochemistry 35:4155-60
89. Miralles A, Asensio VJ, Garcia-Sevilla JA. 2002. Acute treatment with the cyclic antidepressant desipramine, but not fluoxetine, increases membrane-associated G protein-coupled receptor kinases 2/3 in rat brain. Neuropharmacology 43:1249-57
90. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. 1998. Dopamine receptors: from structure to function. Physiol. Rev. 78:189-225
91. Neill JD, Musgrove LC, Duck LW, Sellers JC. 1999. High efficiency method for gene transfer in normal pituitary gonadotropes: adenoviral-mediated expression of G protein-coupled receptor kinase 2 suppresses luteinizing hormone secretion. Endocrinology 140:2562-69
92. Nestler EJ, Aghajanian GK. 1997. Molecular and cellular basis of addiction. Science 278:58-63
93. Nestler EJ. 2001. Molecular basis of long-term plasticity underlying addiction. Nature Rev. Neurosci. 2:119-28
94. Neubig RR, Siderovski DP. 2002. Regulators of G-protein signalling as new central nervous system drug targets. Nat. Rev. Drug Discov. 1:187-97
95. Noble F, Cox BM. 1996. Differential desensitization of mu- and delta-opioid receptors in selected neural pathways following chronic morphine treatment. Br. J. Pharmacol. 117:161-69
96. Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS. 2000. Differential affinities of visual arrestin, beta arrestin 1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J. Biol. Chem. 275:17201-10
97. Ohguro H, Chiba S, Igarashi Y, Matsumoto H, Akino T, Palczewski K. 1993. Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients. Proc. Natl. Acad. Sci. USA 90:3241-45
98. Ohsawa M, Mizoguchi H, Narita M, Nagase H, Dun NJ, Tseng LF. 2003. Involvement of beta-arrestin-2 in modulation of the spinal antinociception induced by mu-opioid receptor agonists in the mouse. Neurosci. Lett. 346:13-16
99. Overstreet DH, Miller CS, Janowsky DS, Russell RW. 1996. Potential animal model of multiple chemical sensitivity with cholinergic supersensitivity. Toxicology 111:119-34
100. Ozaita A, Escriba PV, Ventayol P, Murga C, Mayor F Jr, Garcia-Sevilla JA. 1998. Regulation of G protein-coupled receptor kinase 2 in brains of opiate-treated rats and human opiate addicts. J. Neurochem. 70:1249-57
101. Pandey GN, Garver DL, Tamminga C, Ericksen S, Ali SI, Davis JM. 1977. Postsynaptic supersensitivity in schizophrenia. Am. J. Psychiatry 134:518-22
102. Parruti G, Peracchia F, Sallese M, Ambrosini G, Masini M, et al. 1993. Molecular analysis of human beta-arrestin-1: cloning, tissue distribution, and regulation of expression. Identification of two isoforms generated by alternative splicing. J. Biol. Chem. 268:9753-61
103. Penela P, Alvarez-Dolado M, Munoz A, Mayor F Jr. 2000. Expression patterns of the regulatory proteins G protein-coupled receptor kinase 2 and beta-arrestin 1 during rat post-natal brain development: effect of hypothyroidism. Eur. J. Biochem. 267:4390-96
104. Penn RB, Pronin AN, Benovic JL. 2000. Regulation of G protein-coupled receptor kinases. Trends Cardiovasc. Med. 10:81-89
105. Peppel K, Boekhoff I, McDonald P, Breer H, Caron MG, Lefkowitz RJ. 1997. G protein-coupled receptor kinase 3 (GRK3) gene disruption leads to loss of odorant receptor desensitization. J. Biol. Chem. 272:25425-28
106. Perroy J, Adam L, Qanbar R, Chenier S, Bouvier M. 2003. Phosphorylation-independent desensitization of GABA(B) receptor by GRK4. EMBO J. 22:3816-24
107. Perry SJ, Lefkowitz RJ. 2002. Arresting developments in heptahelical receptor signaling and regulation. Trends Cell Biol. 12:130-38
108. Picetti R, Saiardi A, Abdel Samad T, Bozzi Y, Baik JH, Borrelli E. 1997. Dopamine D2 receptors in signal transduction and behavior. Crit. Rev. Neurobiol. 11:121-42
109. Pitcher JA, Freedman NJ, Lefkowitz RJ. 1998a. G protein-coupled receptor kinases. Annu. Rev. Biochem. 67:653-92
110. Pitcher JA, Hall RA, Daaka Y, Zhang J, Ferguson SS, et al. 1998b. The G protein-coupled receptor kinase 2 is a microtubule-associated protein kinase that phosphorylates tubulin. J. Biol. Chem. 273:12316-24
111. Premont RT, Koch WJ, Inglese J, Lefkowitz RJ. 1994. Identification, purification, and characterization of GRK5, a member of the family of G protein-coupled receptor kinases. J.Biol. Chem. 269:6832-41
112. Premont RT, Inglese J, Lefkowitz RJ. 1995. Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J. 9:175-82
113. Premont RT, Macrae AD, Stoffel RH, Chung N, Pitcher JA, et al. 1996. Characterization of the G protein coupled receptor kinase GRK4. Identification of four splice variants. J. Biol. Chem. 271:6403-10
114. Premont RT, Macrae AD, Aparicio SA, Kendall HE, Welch J, Lefkowitz RJ. 1999. The GRK4 subfamily of G protein-coupled receptor kinases: alternative splicing, gene organization and sequence conservation. J. Biol. Chem. 274:29381-89
115. Premont RT, Gainetdinov RR, Caron MG. 2001. Following the trace of elusive amines. Proc. Natl. Acad. Sci. USA 98:9474-75
116. Pronin AN, Satpaev DK, Slepak VZ, Benovic JL. 1997. Regulation of G protein-coupled receptor kinases by calmodulin and localization of the calmodulin binding domain. J. Biol. Chem. 272:18273-80
117. Pronin AN, Morris AJ, Surguchov A, Benovic JL. 2000. Synucleins are a novel class of substrates for G protein-coupled receptor kinases. J. Biol. Chem. 275:26515-22
118. Przewlocka B, Sieja A, Starowicz K, Maj M, Bilecki W, Przewlocki R. 2002. Knockdown of spinal opioid receptors by antisense targeting beta-arrestin reduces morphine tolerance and allodynia in rat. Neurosci. Lett. 325:107-10
119. Rahman Z, Schwarz J, Gold SJ, Zachariou V, Wein MN, et al. 2003. RGS9 modulates dopamine signaling in the basal ganglia. Neuron 38:941-52
120. Robinson TE, Berridge KC. 1993. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18:247-91
121. Rockman HA, Choi DJ, Rahman NU, Akhter SA, Lefkowitz RJ, Koch WJ. 1996. Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice. Proc. Natl. Acad. Sci. USA 93:9954-59
122. Rockman HA, Choi DJ, Akhter SA, Jaber M, Giros B, et al. 1998. Control of myocardial contractile function by the level of beta-adrenergic receptor kinase 1 in gene-targeted mice. J. Biol. Chem. 273:18180-84
123. Rockman HA, Koch WJ, Lefkowitz RJ. 2002. Seven-transmembrane-spanning receptors and heart function. Nature 415:206-12
124. Sallese M, Salvatore L, D'Urbano E, Sala G, Storto M, et al. 2000. The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1. FASEB J. 14:2569-80
125. Sapolsky RM. 1998. The stress of Gulf War syndrome. Nature 393:308-9
126. Schulz R, Wehmeyer A, Murphy J, Schulz K. 1999. Phosducin, beta-arrestin and opioid receptor migration. Eur. J. Pharmacol. 375: 349-57
127. Schwartz JC, Levesque D, Martres MP, Sokoloff P. 1993. Dopamine D3 receptor: basic and clinical aspects. Clin. Neuropharmacol. 16:295-314
128. Shenoy SK, Lefkowitz RJ. 2003. Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem. J. 375:503-15
129. Sibley DR. 1999. New insights into dopamine receptor function using antisense and genetically altered animals. Annu. Rev. Pharmacol. Toxicol. 39:313-41
130. Sills TL, Fletcher PJ. 1997. Fluoxetine attenuates morphine-induced locomotion and blocks morphine-sensitization. Eur. J. Pharmacol. 337:161-64
131. Sim LJ, Selley DE, Dworkin SI, Childers SR. 1996. Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain. J Neurosci. 16:2684-92
132. Singer HS. 1994. Neurobiological issues in Tourette syndrome. Brain Dev, 16:353-64
133. Seeman P, Van Tol HH. 1994. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15:264-70
134. Snyder SH, Pasternak GW. 2003. Historical review: opioid receptors. Trends Pharmacol. Sci. 24:198-205
135. Sterne-Marr R, Benovic JL. 1995. Regulation of G protein-coupled receptors by receptor kinases and arrestins. Vitam. Horm. 51:193-234
136. Stoffel RH, Randall RR, Premont RT, Lefkowitz RJ, Inglese J. 1994. Palmitoylation of G protein-coupled receptor kinase, GRK6: lipid modification diversity in the GRK family. J. Biol. Chem. 269:27791-94
137. Stoffel RH, Inglese J, Macrae AD, Lefkowitz RJ, Premont RT. 1998. Palmitoylation increases the kinase activity of the G protein-coupled receptor kinase, GRK6. Biochemistry 37:16053-59
138. Sunayashiki-Kusuzaki K, Kikuchi T, Wawrousek EF, Shinohara T. 1997. Arrestin and phosducin are expressed in a small number of brain cells. Brain Res. Mol. Brain Res. 52:112-20
139. Tao R, Auerbach SB. 1994. Increased extracellular serotonin in rat brain after systemic or intraraphe administration of morphine. J. Neurochem. 63:517-24
140. Terman GW, Jin W, Cheong YP, Lowe J, Caron MG, et al. 2004. G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal. Br. J. Pharmacol. 141:55-64
141. Terwilliger RZ, Ortiz J, Guitart X, Nestler EJ. 1994. Chronic morphine administration increases β-adrenergic receptor kinase (βARK) levels in the rat locus coeruleus. J. Neurochem. 63:1983-86
142. Tiberi M, Nash SR, Bertrand L, Lefkowitz RJ, Caron MG. 1996. Differential regulation of dopamine D1a responsiveness by various G protein-coupled receptor kinases. J. Biol. Chem. 271:3771-78
143. Uhl GR, Sora I, Wang Z. 1999. The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. Proc. Natl. Acad. Sci. USA 96:7752-55
144. Vassilatis DK, Hohmann JG, Zeng H, Li F, Ranchalis JE, et al. 2003. The G protein-coupled receptor repertoires of human and mouse. Proc. Natl. Acad. Sci. USA 100:4903-8
145. Vroon A, Heijnen CJ, Raatgever R, Touw JP, Ploemacher RE, et al. 2004. GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo. J. Leukoc. Biol. 75:doi:10.1189/jlb.0703320. In press
146. Walker JKL, Peppel K, Lefkowitz RJ, Caron MG, Fisher JT. 1999. Altered airway and cardiac responses in mice lacking G protein-coupled receptor kinase 3. Am. J. Physiol. 276:R1214-21
147. Walker JKL, Fong AM, Lawson BL, Savov JD, Patel DD, et al. 2003. Beta-arrestin-2 regulates the development of allergic asthma. J. Clin. Invest. 112:566-74
148. Walker JKL, Gainetdinov RR, Feldman DS, McFawn PK, Caron MG, et al. 2004. G protein-coupled receptor kinase 5 regulates airway responses induced by muscarinic receptor activation. Am. J. Physiol. Lung Cell. Mol. Physiol. 286:L312-19
149. Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, et al. 1997. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 19:1285-96
150. Watanabe H, Xu J, Bengra C, Jose PA, Felder RA. 2002. Desensitization of human renal D1 receptors by G protein-coupled receptor kinase 4. Kidney Int. 62:790-98
151. Watson S, Arkinstall S, ed. 1994. The G-Protein Linked Receptor Facts-Book. San Diego: Academic
152. Wess J. 2000. Physiological roles of G-protein-coupled receptor kinases revealed by gene-targeting technology. Trends Pharmacol. Sci. 21:364-67
153. Whistler JL, von Zastrow M. 1998. Morphine-activated opioid receptors elude desensitization by beta-arrestin. Proc. Natl. Acad. Sci. USA 95:9914-19
154. Whistler JL, Chuang HH, Chu P, Jan LY, von Zastrow M. 1999. Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23:737-46
155. Wickman K, Clapham DE. 1995. Ion channel regulation by G proteins. Physiol. Rev. 75:865-85
156. Wilcox RE, Smith RV, Anderson JA, Riffee WH. 1980. Apomorphine-induced stereotypie cage climbing in mice as a model for studying changes in dopamine receptor sensitivity. Pharmacol. Biochem. Behav. 12:29-33
157. Willets J, Kelly E. 2001. Desensitization of endogenously expressed delta-opioid receptors: no evidence for involvement of G protein-coupled receptor kinase 2. Eur. J. Pharmacol. 431:133-41
158. Willets JM, Challiss RA, Nahorski SR. 2003. Non-visual GRKs: Are we seeing the whole picture? Trends Pharmacol. Sci. 24:626-33
159. Wise RA, Bozarth MA. 1987. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:469-92
160. Wise A, Jupe SC, Rees S. 2004. The identification of ligands at orphan G-protein coupled receptors. Annu. Rev. Pharmacol. Toxicol. 44:43-66
161. Yamamoto S, Sippel KC, Berson EL, Dryja TP. 1997. Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness. Nat. Genet. 15:175-78
162. Zachariou V, Georgescu D, Sanchez N, Rahman Z, DiLeone R, et al. 2003. Essential role for RGS9 in opiate action. Proc. Natl. Acad. Sci. USA 100:13656-61
163. Zhang J, Ferguson SS, Barak LS, Bodduluri SR, Laporte SA, et al. 1998. Role for G proteincoupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc. Natl. Acad. Sci. USA 95:7157-62
164. Zhang J, Barak LS, Anborgh PH, Laporte SA, Caron MG, Ferguson SS. 1999. Cellular trafficking of G protein-coupled receptor/beta-arrestin endocytic complexes. J. Biol. Chem. 274:10999-1006